Access to anti-retroviral drugs, male in Portugal
Portugal: Access to anti-retroviral drugs, male was 82.0% in 2017. ▲ Rising
Access to anti-retroviral drugs, male in Portugal, 2000–2017
Source: UNAIDS estimates. Measured in %.
Analysis
Portugal recorded 82.0% for access to anti-retroviral drugs, male in 2017. That is the highest value across all 18 years on record.
Compared with earlier readings it is up 13.9% on the previous year and up 110.3% over ten years.
Over the whole period, access to anti-retroviral drugs, male in Portugal peaked at 82.0% in 2017 and was at its lowest, 15.0%, in 2000.
That places Portugal 42nd out of 141 countries with data for 2017, putting it in the middle of the range.
The long-run direction has been consistently rising across the 18 years of available data.
Access to anti-retroviral drugs, male in Portugal, year by year
| Year | % | Change |
|---|---|---|
| 2000 | 15.0% | — |
| 2001 | 19.0% | +26.7% |
| 2002 | 23.0% | +21.1% |
| 2003 | 26.0% | +13.0% |
| 2004 | 30.0% | +15.4% |
| 2005 | 33.0% | +10.0% |
| 2006 | 36.0% | +9.1% |
| 2007 | 39.0% | +8.3% |
| 2008 | 42.0% | +7.7% |
| 2009 | 45.0% | +7.1% |
| 2010 | 49.0% | +8.9% |
| 2011 | 53.0% | +8.2% |
| 2012 | 58.0% | +9.4% |
| 2013 | 62.0% | +6.9% |
| 2014 | 66.0% | +6.5% |
| 2015 | 69.0% | +4.5% |
| 2016 | 72.0% | +4.3% |
| 2017 | 82.0% | +13.9% |
Portugal compared with similar countries
- Portugal's 82.0% is above the median for high income countries, which is 82.0%, 1.0× the median. (39 countries reporting)
- Portugal's 82.0% is above the median for Europe & Central Asia, which is 82.0%, 1.0× the median. (33 countries reporting)
Biggest year-on-year movements
Years where Access to anti-retroviral drugs, male in Portugal changed far more than this series normally does. A large move can be a real event or a change in how the figure was measured — the source note below says who published it.
| Year | Change | From | To |
|---|---|---|---|
| 2001 | +26.7% | 15.0% | 19.0% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 30.8% | 15.0% | 45.0% | 10 |
| 2010s | 63.9% | 49.0% | 82.0% | 8 |
Countries ranked near Portugal
- 40 Luxembourg 83.0% compare
- 40 Tanzania, United Republic of 83.0% compare
- 42 Guatemala 82.0% compare
- 42 Mozambique 82.0% compare
- 42 Sierra Leone 82.0% compare
More gender data for Portugal
- Child population (UN estimates and projections) 1,308 (2030)
- Child population (UN estimates and projections) (0-14), annual growth 0.1109 % change on previous year (2030)
- Population 9,009 (2030)
- Working-age population (UN estimates and projections) 9,009 (2030)
- Population (UN estimates and projections), annual growth rate -0.2323 % change on previous year (2030)
- Age population, age 00, female, interpolated 41,963 (2025)
- Age population, age 00, male, interpolated 44,232 (2025)
- Age population, age 01, female, interpolated 42,382 (2025)
- Age population, age 01, male, interpolated 44,580 (2025)
- Age population, age 02, female, interpolated 42,087 (2025)
Frequently asked questions
- What is access to anti-retroviral drugs, male in Portugal?
- Access to anti-retroviral drugs, male in Portugal was 82.0% in 2017, according to UNAIDS estimates.
- What is the highest access to anti-retroviral drugs, male recorded in Portugal?
- The highest recorded value was 82.0% in 2017.
- What is the lowest access to anti-retroviral drugs, male recorded in Portugal?
- The lowest recorded value was 15.0% in 2000.
- How does Portugal rank for access to anti-retroviral drugs, male?
- Portugal ranks 42nd out of 141 countries with data for 2017.
- Is access to anti-retroviral drugs, male rising or falling in Portugal?
- Over the last ten years it is up 110.3%. The long-run trend across the full record is rising.
- Where does this Portugal data come from?
- The figures come from UNAIDS estimates, published as part of Access to anti-retroviral drugs, male (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 18 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.